mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.097 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |